Brian Nappi News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Brian Nappi. Real-time updates on events, politics, business and more.

Saol Therapeutics enhances its IP portfolio for Dichloroacetate (DCA; SL-1009) in Glioblastoma and Rare Pediatric Cancers

March 16, 2023

/PRNewswire/ -- Saol Therapeutics ("Saol"), a privately held, clinical-stage pharmaceutical company, announced today the signing of an agreement with Medosome...

Biochim Biophys Acta Medosome Biotec David Penake Piccolic Dichloroacetate Virinder Nohria Brian Nappi

Source: prnewswire.com

Saol Therapeutics and InformedDNA Partner to Offer Genetic Counseling to Patients with Rare Mitochondrial Disease

April 26, 2022

/PRNewswire/ -- Saol Therapeutics, a company researching new treatments for rare diseases, is pleased to announce a partnership with InformedDNA®, the nations...

Kathy Dorsey Dave Penake Brian Nappi Megan Smith Karmen Trzupek Peter Stacpoole

Source: prnewswire.com

Saol Therapeutics and InformedDNA Partner to Offer Genetic Counseling to Patients with Rare Mitochondrial Disease

April 26, 2022

Program Discusses Access to a Pivotal Phase 3 Trial of Dichloroacetate in Pyruvate Dehydrogenase Complex Deficiency (DCA/PDCD trial; NCT02616484)R...

United States Sankt Peterburg Kathy Dorsey Dave Penake Brian Nappi Megan Smith

Source: businessinsider.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Brian Nappi News Today

Saol Therapeutics enhances its IP portfolio for Dichloroacetate (DCA; SL-1009) in Glioblastoma and Rare Pediatric Cancers

Saol Therapeutics and InformedDNA Partner to Offer Genetic Counseling to Patients with Rare Mitochondrial Disease

Saol Therapeutics and InformedDNA Partner to Offer Genetic Counseling to Patients with Rare Mitochondrial Disease

Explore More Categories